Study S001575

BALANCE-OBS: A Multiregional, Randomized, Multicenter, Active-Controlled Confirmatory Phase III Study to Evaluate the Efficacy and Safety of Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity

ClinicalTrials.gov record

Registration

Registration: NCT07622810
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 352
Start: 2026-09
Primary completion: 2027-12
Lead sponsor: Carnot Laboratories
Conditions: Obesity & Overweight
Interventions: DRUG:Bofanglutida; DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Percent Change in Body Weight From Baseline to Week 36 [Baseline to Week 36]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.